Ekawat, Hemophilia, Thailand
Sanofi's global specialty care business unit focuses on rare diseases, rare blood disorders, neurology, immunology, and oncology.
Sanofi's ambition is to leverage science and innovation to improve people’s lives and be the industry leader in immunology and oncology.
Its approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities.
Our Responsibility
Sanofi's specialty care business unit supports access to treatment through humanitarian programs to help ensure that appropriate treatment reaches all those who need it.
Pipeline
Sanofi has a strong pipeline with a significant portion of its R&D spending concentrated on specialty care.
Our Stories
Inspired by Rare Disease Patients Around the World
The Impact of COVID-19 on Cancer
Inside Sanofi’s Hemophilia Research
The Type 2 Inflammation Connection
Adjusting to Life with Multiple Myeloma: Bernard’s Story
MAT-GLB-2100978-v1.0-03/2021